Aurora Spine Corporation has launched its DEXA-L™ Anterior Lumbar Interbody Fusion (ALIF) device, with the first procedures already completed in the United States.
The new product extends the company’s patented DEXA™ Technology Platform, the first range of bone density-matched spinal implants.
DEXA-L™ is designed as a stand-alone implant for ALIF surgery. It is the first spinal device engineered to mimic bone structure and to match the density and quality of each patient’s bone.
‘This personalised approach aims to improve outcomes for people with normal bone mass as well as those with low bone density, such as osteopenia or osteoporosis.
The system has been developed to address a major gap in spinal surgery where implant modulus is not typically matched to a patient’s bone quality.
According to public health data, a significant proportion of older adults have low bone mass, making implant selection and stability a clinical challenge.
Aurora Spine’s DEXA-L™ builds on the success of its DEXA-C™ cervical fusion implant, which has been widely adopted in the United States.
The company expects the new lumbar system to reduce complications such as subsidence and to expand surgical options for more patients.
